Clinical Trials Insight: 700013234
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 13 May 2008
At a glance
- Drugs Influenza A virus vaccine-H9N2 (Primary)
- Indications Influenza A virus H9N2 subtype
- Focus Pharmacodynamics
- Sponsors Crucell
- 13 May 2008 Results are expected in the 2nd quarter of 2008.
- 13 Nov 2007 Results are expected in the first half of 2008.
- 21 Nov 2006 Status change